IL-6 R alpha

IL-6 R alpha 詳細

英語名Interleukin-6 receptor alpha subunit市販薬剤の数8
治験薬の数9ターゲットの別称IL6RA,IL6RQ,IL6Q,Interleukin-6 Receptor alpha Subunit,sIL6R,gp80,IL-6R subunit alpha,Membrane glycoprotein 80,IL6R,Interleukin 6 Receptor,IL-6 Receptor Subunit Alpha,CD126 Antigen,IL-6R 1,IL-6RA,Interleukin-6 Receptor Subunit Alpha,IL-6R-Alpha,IL-6R-1,CD126
研究&開発段階Approved
英語名Interleukin-6 receptor alpha subunit
ターゲットの別称IL6RA,IL6RQ,IL6Q,Interleukin-6 Receptor alpha Subunit,sIL6R,gp80,IL-6R subunit alpha,Membrane glycoprotein 80,IL6R,Interleukin 6 Receptor,IL-6 Receptor Subunit Alpha,CD126 Antigen,IL-6R 1,IL-6RA,Interleukin-6 Receptor Subunit Alpha,IL-6R-Alpha,IL-6R-1,CD126
市販薬剤の数8
治験薬の数9
研究&開発段階Approved

IL-6 R alpha 製品リスト

  • 属性

    Protein (7)

  • 製品ライブラリ

    オンライン (7)

  • Human (4)Mouse (2)Rhesus macaque (1)

  • タグ

    His Tag (2)His Tag & Avi Tag (2)Fc Tag (2)Fc Tag & Avi Tag (1)

  • マーカー

    Unconjugated (4)Biotin-labeled (3)

IL-6 R alphaバックグランド

Interleukin 6 receptor (IL6R) is also known as CD126 (Cluster of Differentiation 126) , is a potent pleiotropic cytokine that regulates cell growth and differentiation of various tissues, and is known particularly for its role in the immune response and acute phase reactions. IL6R is a protein complex consisting of a IL-6 receptor subunit (IL6R) and interleukin 6 signal transducer Glycoprotein 130. IL6R also denotes the human gene encoding this subunit. Alternatively spliced transcript variants encoding distinct isoforms have been reported. IL6R subunit also shared by many other cytokines. The soluble form of IL6R arises from proteolytic cleavage of membrane-bound IL6Rα, and acts agonistically by making the IL6 ligand accessible to the signal transducer gp130. Dysregulated production of IL6 and IL6R are implicated in the pathogenesis of several inflammatory diseases and malignancies such as multiple myeloma, rheumatoid arthritis, or osteoporosis, and it has been reported that a humanized anti-IL6R monoclonal antibody is a promising agent applicable to the therapeutic approach for IL6 driven diseases. Interleukin-6 receptor has been shown to interact with Interleukin 6 and Ciliary neurotrophic factor.

IL-6 R alpha分子の別称

IL6R,CD126,IL-6R-1,IL-6RA,IL6RA,IL-6R-alpha,IL6RQ,gp80

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Recombinant humanized anti-IL-6R antibody (Hisun Pharma)HS-628Phase 3 ClinicalZhejiang Hisun Pharmaceutical Co LtdArthritis; Arthritis, Rheumatoid
詳細
VDJ-001Phase 3 ClinicalBeijing Vdjbio Co LtdArthritis, Rheumatoid; Cardiovascular Diseases; Castleman Disease; Graves Ophthalmopathy; Multicentric Castleman's Disease (MCD); Renal Insufficiency, Chronic
詳細
Tocilizumab Biosimilar (Curateq Biologics)BP08; BP-08Phase 3 ClinicalCuraTeQ Biologics Pvt LtdArthritis, Rheumatoid
詳細
Tocilizumab biosimilar (GENERIUM Pharmaceuticals)GNR-087Phase 3 ClinicalGenerium PharmaceuticalsArthritis, Rheumatoid
詳細
Tocilizumab biosimilar (AryoGen Pharmed)Phase 3 ClinicalAryogen BiopharmaArthritis, Rheumatoid
詳細
Tocilizumab biosimilar(Hetero Biopharma)Phase 3 ClinicalHetero Biopharma LtdArthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)
詳細
LevilimabBCD-089Phase 3 ClinicalBIOCAD JSCArthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19)
詳細
Atexakin alfaSON-080; r-IL-6Phase 2 ClinicalWeizmann Institute Of ScienceDiabetic Neuropathies; Peripheral Nervous System Diseases
詳細
OlamkiceptFE-999301; CR-5/18; TJ-301; FE-301Phase 1 ClinicalConaris Research InstituteColitis, Ulcerative; Gastrointestinal Diseases
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
TocilizumabMRA-SC; R-1569; rhPM-1; RO-48775533; MRA; RG-1569; HPM-1ApprovedChugai Pharmaceutical Co LtdActemra, Acterma, ACTPen, RoActemra, 雅美罗JapanArthritis, RheumatoidChugai Pharmaceutical Co Ltd2005-04-11Acute Chest Syndrome; Amyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Arthritis, Juvenile; Arthritis, Rheumatoid; Ascites; Behcet Syndrome; Breast Neoplasms; Carcinoma, Hepatocellular; Chondrocalcinosis; Coronary Artery Disease; Coronary Disease; Coronavirus Disease 2019 (COVID-19); Coronavirus Infections; Craniopharyngioma; Cytokine Release Syndrome; Depressive Disorder, Major; Dermatomyositis; Diabetes Mellitus; Diabetes Mellitus, Type 1; Fever; Giant Cell Arteritis; Graft vs Host Disease; Graves Ophthalmopathy; Hematologic Neoplasms; HIV Infections; Inflammation; Ischemic Stroke; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Lymphoma; Motor Neuron Disease; Myocardial Infarction; Neoplasms; Non-radiographic axial spondyloarthritis; Non-ST Elevated Myocardial Infarction; Osteoarthritis; Pancreatitis, Chronic; Panuveitis; Pleural Effusion, Malignant; Pneumonia; Polyarticular Juvenile Idiopathic Arthritis; Polymyalgia Rheumatica; Polymyositis; Pulmonary Arterial Hypertension; Pulmonary Disease,
詳細
Tocilizumab biosimilar (Bio-Thera Solutions)BAT-1806; BIIB-800ApprovedBio-Thera Solutions Ltd施瑞立, TOFIDENCEMainland ChinaArthritis, Rheumatoid; Arthritis, Juvenile; Cytokine Release SyndromeBio-Thera Solutions Ltd2023-01-16Arthritis, Juvenile; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Polyarticular Juvenile Idiopathic Arthritis
詳細
SarilumabSAR-153191; REGN-88ApprovedRegeneron Pharmaceuticals Inc, SanofiKevzaraUnited StatesArthritis, RheumatoidSanofi-Synthelabo2017-05-22Arthritis, Juvenile; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Mastocytosis, Systemic; Polyarticular Juvenile Idiopathic Arthritis; Polymyalgia Rheumatica; Sarcoidosis; Severe Acute Respiratory Syndrome; Spondylitis, Ankylosing; Uveitis
詳細
Tocilizumab biosimilar (Livzon Group)LZM-008ApprovedLivzon Pharmaceutical Group Inc安维泰Mainland ChinaArthritis, RheumatoidLivzon Mabpharm Inc2023-01-18Arthritis, Rheumatoid
詳細
Tocilizumab biosimilar (Fresenius kabi)MSB-11456; AT-220 (Arecor Therapeutics)ApprovedMerck SeronoTyenneEUCoronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Arthritis, Rheumatoid; Giant Cell ArteritisFresenius Kabi Deutschland Gmbh2023-09-15Arthritis, Rheumatoid; Brain Ischemia; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Subarachnoid Hemorrhage
詳細
Tocilizumab biosimilar (BioRay Pharm)ApprovedHisun Biopharmaceutical Co LtdMainland ChinaArthritis, RheumatoidHisun Biopharmaceutical Co Ltd2024-06-25Arthritis, Rheumatoid
詳細
Tocilizumab biosimilar (Celltrion)CT-P47; CT-P-47ApprovedCelltrion IncAvtozmaUnited StatesGiant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis; Coronavirus Disease 2019 (COVID-19); Arthritis, Juvenile; Arthritis, RheumatoidCelltrion Inc2025-01-24Arthritis, Juvenile; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Giant Cell Arteritis; Polyarticular Juvenile Idiopathic Arthritis
詳細
Tocilizumab biosimilar (Maibo Taike)CMAB-806; CMAB806ApprovedJinyu Bowo Runze Biotechnology Co Ltd, Taizhou Maibo Taike Biotechnology Co LtdMainland ChinaArthritis, RheumatoidJinyu Bowo Runze Biotechnology Co Ltd2024-10-16Arthritis; Arthritis, Rheumatoid
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8